ArticleCell death & disease2019

Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy.

Lisa Pfitzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.